Trials / Recruiting
RecruitingNCT03792854
Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer
Detailed description
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer. Qol will be evaluated by standardized EORTC questionaires QLQ C30 and QLQ CR29. Acute and late toxicity will be assessed according to CTCAE 4.03. Oncological outcome will be assessed with regard to local and distant control, patterns of recurrence, freedom from treatment failure and overall survival. Correlations of physicians- and patients-assessed functional outcomes are planned.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | EORTC QLQ C30 | standardized questionaire |
| OTHER | EORTC QLQ CR29 | standardized questionaire |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2021-12-01
- Completion
- 2026-12-01
- First posted
- 2019-01-03
- Last updated
- 2019-01-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03792854. Inclusion in this directory is not an endorsement.